Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2021 Dividend
May 20 2021 - 4:30PM
Business Wire
Zoetis Inc. (NYSE:ZTS) today announced the results of
shareholder voting at its 2021 Annual Meeting of Shareholders and
provided details on its third quarter 2021 dividend.
Virtual Annual Meeting of Shareholders
Zoetis held a virtual annual meeting today, with Chairman
Michael B. McCallister presiding over the business portion of the
meeting and shareholder voting. Chief Executive Officer Kristin
Peck discussed the company’s strong performance in 2020 resulting
from the resilience of Zoetis colleagues and the essential nature
of the company’s animal health products. “We achieved operational
revenue growth of 9% and grew adjusted net income 10% operationally
in 2020. We also generated a strong cash flow that enabled us to
protect jobs, ensure the safety of our colleagues, maintain
reliable supply for customers, continue investing in our long-term
growth plans, and return excess capital to our shareholders,” said
Peck.
Peck also discussed several highlights from the last year,
including new innovations in the company’s companion animal
portfolio such as Simparica Trio®; growth in key markets outside
the U.S., including Brazil and China; accelerated sales of
diagnostic products; and publication of the company’s long-term
Sustainability goals.
Looking ahead, Peck said, “I am pleased to say we are off to a
very strong start in 2021 and recently raised guidance for the full
year based on continued confidence in our diverse portfolio, our
pipeline of innovations, and the catalysts we see in petcare,
diagnostics and our high-growth international markets.”
Shareholder Voting Results
The results of shareholder voting from the meeting were as
follows:
- Sanjay Khosla, Antoinette R. Leatherberry, Willie M. Reed and
Linda Rhodes have been elected as directors for three-year
terms.
- Shareholders approved, on an advisory basis, the compensation
of the company’s named executive officers.
- Shareholders ratified and approved the selection of KPMG LLP as
the company’s independent registered public accounting firm for
fiscal year 2021.
- Shareholders approved a shareholder proposal that asks Zoetis’
Board of Directors to replace the supermajority voting provisions
in the company’s organizational documents with a simple majority
vote standard.
Quarterly Dividend Declared
In separate proceedings today, the Zoetis Board of Directors
declared a third quarter 2021 dividend payable to holders of the
company’s common stock of $0.25 per share. The dividend is to be
paid on Wednesday, Sept. 1, 2021, to holders of record on
Wednesday, July 21, 2021.
About Zoetis
As the world’s leading animal health company, Zoetis is driven
by a singular purpose: to nurture our world and humankind by
advancing care for animals. After nearly 70 years innovating ways
to predict, prevent, detect, and treat animal illness, Zoetis
continues to stand by those raising and caring for animals
worldwide - from livestock farmers to veterinarians and pet owners.
The company’s leading portfolio and pipeline of medicines,
vaccines, diagnostics and technologies make a difference in over
100 countries. In 2020, Zoetis generated revenue of $6.7 billion
with ~11,300 employees. For more, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
the current views of Zoetis with respect to business plans or
prospects, future operating or financial performance, future use of
cash and dividend payments, and other future events. These
statements are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.
A further list and description of risks, uncertainties and other
matters can be found in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2020, including in the sections
thereof captioned “Forward-Looking Statements and Factors That May
Affect Future Results” and “Item 1A. Risk Factors,” in our
Quarterly Reports on Form 10-Q and in our Current Reports on Form
8-K. Such risks and uncertainties may be amplified by the COVID-19
pandemic and its potential impact on the global economy and our
business. These filings and subsequent filings are available online
at www.sec.gov, www.zoetis.com, or on request from Zoetis.
ZTS-COR ZTS-IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210520006053/en/
Media Contacts: Bill Price
1-973-443-2742 (o) william.price@zoetis.com Kristen Seely
1-973-443-2777 (o) kristen.seely@zoetis.com Investor Contacts: Steve Frank 1-973-822-7141 (o)
steve.frank@zoetis.com Keith Gaub 1-973-822-7154 (o)
keith.gaub@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Oct 2023 to Oct 2024